Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases.
Angiogenesis supports normal physiology as well as contributing to the progression of various diseases including cancer. Determination of the key role of angiogenesis in cancer has led to much optimism for the development of targeted drugs without cytotoxic side-effects. Currently, research in angiogenesis therapy is robust, with the discovery of a growing number of pro- and anti-angiogenic molecules. More time, however, is required to be able to elucidate the complex interactions among these molecules, how they affect vasculature and their functions in different environments. As we learn more about the molecular mechanisms of angiogenesis, a number of effective methods to treat cancer and other diseases will be developed.
Pralhad
Tayade
T
Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai-400 098, India. pralhad_tayade@rediffmail.com
Madhusudan
Saraf
S
Rajendrakumar
Kale
K
D043925:Angiogenesis Inducing Agents / Q000378:metabolism / Q000494:pharmacology*; D020533:Angiogenesis Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D001808:Blood Vessels / Q000254:growth & development / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D018919:Neovascularization, Physiologic
D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors